2019 American Transplant Congress

Monday, June 3, 2019

3:30pm-3:42pm

Circulating Mirnas Regulate Gene Expression In Kidney Tissue During Transplant Glomerulopathy

C. Kuscu¹, V. Sai Bontha¹, C. Kuscu¹, D. Maluf¹, A. Bajwa¹, J. Eason¹, V. Mas¹, E. Akalin²

Concurrent Session: Kidney Complications: Late Graft Failure II  •  Veterans Auditorium

3:30pm-3:42pm

Elevated Podocyte-specific Urinary Extracellular Vesicles In Patients With Fsgs Recurrence After Kidney Transplantation

H. Lau, A. Shimomura, E. Tantisattamo, U. G. Reddy, D. Dafoe, H. Ichii

Concurrent Session: Biomarkers, Immune Monitoring and Outcomes II  •  Room 306

3:30pm-3:42pm

Geographic Disparities in Heart Transplant Rates

M. Kosztowski, S. Yu, A. Kilic, A. Massie, S. Zhou, D. Segev, S. Gentry

Concurrent Session: Donor and Recipient Selection in Heart Transplanation  •  Room 206

3:30pm-3:42pm

Graft Perfusion with Alvespimycin, an HSP90 Inhibitor, Suppresses IL-2 and IL-12p40 Production in Graft-Infiltrating Cells, Leading to Prolongation of Graft Survival in Murine Heart Transplantation

T. Tanaka, T. Maehana, N. Masumori

Concurrent Session: Immunosuppression Preclinical Studies  •  Room 309

3:30pm-3:42pm

Increased Access to Transplantation for Medicaid Patients Following Medicaid Expansion

A. Massie, M. Henderson, T. Hwee, D. Segev

Concurrent Session: Quality Assurance Process Improvement & Regulatory Issues I  •  Room 210

3:30pm-3:42pm

Kidney Donor Outcomes ≥ 50 Years Post Donation

D. Keys, S. Jackson, A. Matas

Concurrent Session: Kidney Donor Selection / Management Issues II  •  Ballroom C

3:30pm-3:42pm

Kidney Xenotransplantation from Genetically Engineered Pigs to Baboons with FDA-Approved Immunosuppressive Therapy

T. Yamamoto¹, H. Hara¹, J. Foote¹, E. C. Klein², H. J. Schuurman³, L. Wang¹, Q. Li¹, H. Zhou¹, J. Li¹, J. A. Tector¹, Z. Zhang², M. Ezzelarab², R. Lovingood¹, D. Ayares⁴, D. E. Eckhoff¹, D. K. Cooper¹, H. Iwase¹

Concurrent Session: Xenotransplantation  •  Room 310

3:30pm-3:42pm

Patterns of Rejection in Murine, Porcine, and Human Vascularized Composite Allografts Based on Clinical, Histologic, and Immunohistochemical Analysis

M. J. Grzelak, J. W. Etra, F. A. Chang, G. J. Furtmüller, A. R. Ahmadi, F. Nägele, Y. Guo, K. Kambarashvili, A. Jain, S. A. Beck, C. F. Brayton, I. B. Sander, W. A. Lee, G. Brandacher

Concurrent Session: Basic & Clinical Science - VCA  •  Room 209

3:30pm-3:42pm

Post-operative Opioid Requirements In Living Kidney And Liver Donors

H. J. Braun, D. Adelmann, T. Grace, M. E. Pulcrano, C. U. Niemann, N. L. Ascher

Concurrent Session: Surgical Issues: All Organs  •  Room 208

3:30pm-3:42pm

Predictors of Multidrug-Resistant Organisms among Solid Organ Transplant Donors

J. A. Anesi¹, E. A. Blumberg¹, J. H. Han¹, D. H. Lee², H. Clauss³, A. Climaco⁴, R. Hasz⁵, E. Molnar³, D. Alimenti¹, S. West⁵, W. Bilker¹, P. Tolomeo¹, E. Lautenbach¹

Concurrent Session: Infectious Epidemiology  •  Room 304